In the highly regulated world of medical technology, risk management for medical devices is not optional—it’s a compliance requirement. Every device, from diagnostic wearables to complex surgical systems, must be designed and manufactured with patient safety in mind. The international standard ISO 14971 provides the foundation for this process, helping organizations identify, evaluate, and control the risks associated with medical devices throughout their entire lifecycle.

A structured risk management process isn’t just about passing audits—it’s about protecting patients and your bottom line.

What is ISO 14971?

ISO 14971:2019 is the globally recognized standard for risk management for medical devices. It outlines a structured framework for identifying potential hazards, estimating and evaluating associated risks, implementing controls, and monitoring their effectiveness over time.

The standard applies to all medical devices, including software-as-a-medical-device (SaMD) and in vitro diagnostic devices. According to the FDA’s definition (section 201[h] of the Food, Drug, and Cosmetic Act), a medical device is defined as:

  1. Any instrument, apparatus, machine, contrivance, implant, in vitro reagent, or related article (including a component part or accessory)
  2. Recognized in the official National Formulary, the United States Pharmacopoeia, or any supplement to them
  3. Intended for diagnosing, curing, mitigating, treating, or preventing disease in humans or animals
  4. Intended to affect the structure or function of the body without doing so through chemical action or by being metabolized.

ISO 14971 ensures that all products intended for clinical use—hardware, software, or integrated systems—follow the same rigorous approach to safety and performance.

ISO 14971 for Risk Management for Medical Devices

Process

ISO 14971 describes a comprehensive, six-stage risk management process that should be applied from early concept through post-market surveillance.

  1. Establish a Risk Management System: Manufacturers must define a formal process for identifying and controlling risk. This includes management responsibilities, assigning competent personnel, setting risk-acceptance criteria, and creating both a risk management plan and a risk management file to ensure full traceability.
  2. Conduct Risk Analysis: This phase focuses on identifying hazards, hazardous situations, and potential harms. Teams document the device’s intended use and foreseeable misuse, estimate the probability and severity of harm, and record the findings in the risk management file.
  3. Perform Risk Evaluation: Each identified risk is then evaluated against predefined acceptability criteria. Acceptable risks may be carried forward as residual risk, while unacceptable risks trigger control activities.
  4. Implement Risk Controls: The most effective way to reduce risk is through design by eliminating hazards altogether. If that’s not feasible, manufacturers must introduce protective measures (such as guards or alarms) or provide clear instructions and warnings to mitigate potential harm. Then, verification ensures each control is implemented correctly and effectively.
  5. Review and Verify Risk Management: Before market release, the entire risk management process must be reviewed for completeness and accuracy. This formal review confirms that all hazards have been addressed and that the residual risks are acceptable.
  6. Production and Post-Production Activities: Risk management doesn’t end once the product ships. ISO 14971 requires ongoing collection and analysis of production and field data to detect emerging risks, evaluate whether previous assumptions remain valid, and initiate additional controls when necessary.

Benefits

While ISO 14971 certification is not mandatory, aligning with the standard demonstrates that your organization follows best practices for risk management for medical device development. The benefits include:

  • Improved patient and user safety: Reducing the likelihood and impact of device failures or misuse.
  • Streamlined regulatory compliance: Supporting faster alignment with related standards such as ISO 13485, IEC 62304, and EU MDR.
  • Better business decisions: A clear risk framework enables informed trade-offs between innovation and safety.
  • Market credibility: Many suppliers and customers prefer working with ISO-compliant partners.
  • Reduced costs and time-to-market: A structured approach minimizes rework, audits, and regulatory delays.

ISO 14971 gives manufacturers a defensible, repeatable process for demonstrating that safety and efficacy have been systematically verified.

Establishing ISO 14971 Compliance with Codebeamer ALM

Managing risk manually, especially across distributed teams and complex product lines, can quickly become unmanageable. That’s why leading MedTech companies rely on Codebeamer ALM, PTC’s Application Lifecycle Management platform, purpose-built for regulatory environments.

Codebeamer simplifies ISO 14971 compliance by providing:

  • Built-in risk management workflows: Automate hazard identification, risk assessment, and traceability across design and test artifacts.
  • Centralized documentation: Maintain a complete, audit-ready risk management file with version control and electronic signatures.
  • End-to-end traceability: Link requirements, test cases, and verification steps to demonstrate control effectiveness.
  • Integration with multiple quality standards: Aligns with ISO 13485, IEC 62304, and FDA 21 CFR Part 820 to streamline documentation for audits and submissions.
  • Faster time to market: Automation reduces manual effort while improving visibility and collaboration across engineering and compliance teams.

By embedding ISO 14971 processes directly into your product lifecycle, Codebeamer transforms risk management from a regulatory burden into a competitive advantage—helping your organization deliver safer, higher-quality medical devices, faster.

Ready to get started with Codebeamer ALM? Contact us.